Literature DB >> 2996779

Microinjection of the ras oncogene protein into PC12 cells induces morphological differentiation.

D Bar-Sagi, J R Feramisco.   

Abstract

To investigate the possible role of ras proteins in the differentiation process signaled by nerve growth factor, we have microinjected the proto-oncogenic and oncogenic (T24) forms of the human H-ras protein into living rat pheochromocytoma cells (PC12). PC12 cells, which have the phenotype of replicating chromaffin-like cells under normal growth conditions, respond to nerve growth factor by differentiating into nonreplicating sympathetic neuron-like cells. Microinjection of the ras oncogene protein promoted the morphological differentiation of PC12 cells into neuron-like cells. In contrast, microinjection of similar amounts of the proto-oncogene form of the ras protein had no apparent effect on PC12 cells. The induction of morphological differentiation by the ras oncogene protein occurred in the absence of nerve growth factor, was dependent on protein synthesis, and was accompanied by cessation of cell division. Treatment of PC12 cells with nerve growth factor or cAMP analogue prior to injection did not alter the phenotypic changes induced by the ras oncogene protein.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2996779     DOI: 10.1016/0092-8674(85)90280-6

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  164 in total

1.  Phosphatidylinositol 3-kinase, Cdc42, and Rac1 act downstream of Ras in integrin-dependent neurite outgrowth in N1E-115 neuroblastoma cells.

Authors:  S Sarner; R Kozma; S Ahmed; L Lim
Journal:  Mol Cell Biol       Date:  2000-01       Impact factor: 4.272

2.  Downregulation of the Ras-mitogen-activated protein kinase pathway by the EphB2 receptor tyrosine kinase is required for ephrin-induced neurite retraction.

Authors:  S Elowe; S J Holland; S Kulkarni; T Pawson
Journal:  Mol Cell Biol       Date:  2001-11       Impact factor: 4.272

3.  Small GTPase RhoG is a key regulator for neurite outgrowth in PC12 cells.

Authors:  H Katoh; H Yasui; Y Yamaguchi; J Aoki; H Fujita; K Mori; M Negishi
Journal:  Mol Cell Biol       Date:  2000-10       Impact factor: 4.272

4.  Persistent ERK/MAPK activation promotes lactotrope differentiation and diminishes tumorigenic phenotype.

Authors:  Allyson Booth; Tammy Trudeau; Crystal Gomez; M Scott Lucia; Arthur Gutierrez-Hartmann
Journal:  Mol Endocrinol       Date:  2014-12

5.  Specific changes of Ras GTPase-activating protein (GAP) and a GAP-associated p62 protein during calcium-induced keratinocyte differentiation.

Authors:  E Filvaroff; E Calautti; F McCormick; G P Dotto
Journal:  Mol Cell Biol       Date:  1992-12       Impact factor: 4.272

Review 6.  Neuronal cell cultures: a tool for investigations in developmental neurobiology.

Authors:  A Cestelli; G Savettieri; G Salemi; I Di Liegro
Journal:  Neurochem Res       Date:  1992-12       Impact factor: 3.996

7.  Effects of inhibitors and ion substitutions on oscillations of cell membrane potential in cells expressing the RAS oncogene.

Authors:  F Lang; S Waldegger; E Woell; M Ritter; K Maly; H Grunicke
Journal:  Pflugers Arch       Date:  1992-08       Impact factor: 3.657

8.  Role of Unc51.1 and its binding partners in CNS axon outgrowth.

Authors:  Toshifumi Tomoda; Jee Hae Kim; Caixin Zhan; Mary E Hatten
Journal:  Genes Dev       Date:  2004-03-10       Impact factor: 11.361

9.  Global expression analysis identified a preferentially nerve growth factor-induced transcriptional program regulated by sustained mitogen-activated protein kinase/extracellular signal-regulated kinase (ERK) and AP-1 protein activation during PC12 cell differentiation.

Authors:  Steven Mullenbrock; Janki Shah; Geoffrey M Cooper
Journal:  J Biol Chem       Date:  2011-11-07       Impact factor: 5.157

10.  Pituitary somatolactotropes evade an oncogenic response to Ras.

Authors:  Allyson K Roof; Tammy Trudeau; Arthur Gutierrez-Hartmann
Journal:  Mol Cell Endocrinol       Date:  2018-05-09       Impact factor: 4.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.